Predict your next investment

HEALTHCARE | Disease Diagnosis

See what CB Insights has to offer

Stage

Acquired | Acquired

Valuation

$0000 

About Grifols Diagnostic Solutions

Grifols Diagnostic Solutions is a unit under Grifols, which produces plasma medicines for patients and provides hospitals, pharmacies, and healthcare professionals with the tools, information, and services to deliver medical care.

Grifols Diagnostic Solutions Headquarter Location

Spain

Latest Grifols Diagnostic Solutions News

Grifols Installs First-Ever DG Reader Net Analyzer in North America

Mar 22, 2021

Grifols Installs First-Ever DG Reader Net Analyzer in North America Grifols, Barcelona, Spain, announced its first-ever installation in North America of the DG Reader Net semiautomated analyzer, used to facilitate pretransfusion blood type compatibility testing. This platform is now running at ThedaCare Medical Center-Wild Rose in Wisconsin. Many small, specialized laboratories like ThedaCare Medical Center-Wild Rose work hard to offer high quality service in pre-transfusion testing with limited semi-automated solutions available to them, resulting in manual testing that could yield results more difficult to interpret or manage for record keeping and audits. Compact and simple, DG Reader Net automates the reading and interpretation of DG Gel cards, a method that determines the presence of certain antigens in red blood cells and is used to indicate blood type compatibility. As a standalone solution, the DG Reader Net analyzer offers laboratories computer-assisted reading and interpretation of immunohematology (IH) tests with automatic results uploading to the laboratory information system. When paired with other Grifols testing platforms, DG Reader Net allows networks to standardize IH testing no matter the facility size. Before the DG Reader Net was installed, care team members at ThedaCare Medical Center-Wild Rose had to read results and manually enter them into the system. Now, the DG Reader Net gives team members results in minutes, which is crucial for a Critical Access Hospital like ThedaCare Medical Center-Wild Rose where immediate responses for blood transfusions are needed. “When our lab teams draw blood from a patient, we run a series of tests on that blood, and screen for antibodies, antigens, as well as determine the blood type,” says Rebecca Schultz, blood bank key operator, ThedaCare Medical Center-Wild Rose. “The DG Reader Net analyzer reads those results and exports everything to one centralized system. We believe it has the ability to minimize the potential for error and, due to its efficiency, creates additional time for our team members to provide care to our patients.” “We’re proud to be able to implement a semiautomated, intuitive blood banking solution at ThedaCare, ultimately helping reduce the risk associated with manually entering results to the Laboratory Information System, thus increasing patient safety,” says James Martinec, director, North America Marketing, Grifols Diagnostic Solutions. For more information, visit  Grifols . Share:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Grifols Diagnostic Solutions Patents

Grifols Diagnostic Solutions has filed 6 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/23/2015

11/9/2021

Clusters of differentiation, Blood antigen systems, Transfusion medicine, Immunology, Immune system

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/23/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

11/9/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Clusters of differentiation, Blood antigen systems, Transfusion medicine, Immunology, Immune system

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.